Human Procaspase-1 Variants with Decreased Enzymatic Activity Are Associated with Febrile Episodes and May Contribute to Inflammation via RIP2 and NF-κB Signaling-Reference-Cited by-同舟云学术

Human Procaspase-1 Variants with Decreased Enzymatic Activity Are Associated with Febrile Episodes and May Contribute to Inflammation via RIP2 and NF-κB Signaling

Published:2014-04-04 Issue:9 Volume:192 Page:4379-4385
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Heymann Michael C.,Winkler Stefan,Luksch Hella,Flecks Silvana,Franke Marcus,Ruß Susanne,Özen Seza,Yilmaz Engin,Klein Christoph,Kallinich Tilmann,Lindemann Dirk,Brenner Sebastian,Ganser Gerd,Roesler Joachim,Rösen-Wolff Angela,Hofmann Sigrun R.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

2. Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme

3. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines

4. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

5. Immunological and Inflammatory Functions of the Interleukin-1 Family

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the Inflammatory Response Evoked by Bacterial Membrane Vesicles in Intestinal Cells Reveals an RIPK2-Dependent Activation by Enterotoxigenic Escherichia coli Vesicles;Microbiology Spectrum;2023-08-17

2. Apoptosis, necroptosis, and pyroptosis in health and disease;Mechanisms of Cell Death and Opportunities for Therapeutic Development;2022

3. Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity;Clinical Immunology;2021-02

4. RIPK protein kinase family: Atypical lives of typical kinases;Seminars in Cell & Developmental Biology;2021-01

5. Therapeutic modulation of inflammasome pathways;Immunological Reviews;2020-08-07